Dawn K. Reichenbach

Dawn K. Reichenbach

Auto-generated profile, based on publicly available information

Dawn K. Reichenbach

Division of Hematology, Oncology, and Blood and Marrow Transplantation, Department of Pediatrics, University of Minnesota, Minneapolis, MN

Research Focus & Metrics

Academic Career Length

12Years (2015-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
14 May 2015 in Blood
Verified
Journal Article
Open access
PDF file
DRDawn K. Reichenbach
Dawn K. Reichenbach
VSVincent Schwarze
Vincent Schwarze
BMBenjamin M. Matta
Benjamin M. Matta
VTVictor Tkachev
Victor Tkachev
ELElisabeth Lieberknecht
Elisabeth Lieberknecht
BBBruce R. Blazar
Bruce R. Blazar
Key Points: IL-33 and ST2 expression are increased post-conditioning and with GVHD, resulting in increased T-cell activation via the IL-33/ST2 axis. Infusion of ST2-Fc protein exploits sST2’s function as a negative regulator of acute GVHD inhibiting pro-inflammatory cytokines.

21 July 2016 in Blood
Verified
Journal Article
Open access
PDF file
BMBenjamin M. Matta
Benjamin M. Matta
DRDawn K. Reichenbach
Dawn K. Reichenbach
XZXiaoli Zhang
Xiaoli Zhang
LMLisa Mathews
Lisa Mathews
BKBrent H. Koehn
Brent H. Koehn
HTHēth R. Turnquist
Hēth R. Turnquist
Key Points: Peri-alloHCT IL-33 delivery prevents acute GVHD through MAPK-dependent expansion of radiation-resistant recipient ST2+ Tregs. IL-33–expanded Tregs regulate myeloid cell differentiation and activation, and limit effector T-cell accumulation in GVHD-target tissue.